| NCT Number | NCT07468396 |
| Lead Sponsor | Gan & Lee Pharmaceuticals. |
| Conditions | Prostate Cancer |
| Enrollment | 65 participants |
| Start Date | 2026-04-30 |
| Primary Completion | 2031-10-30 (estimated) |
| Study Completion | 2033-04-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-12 |